Brødkrumme Forside Syntaxin Syntaxin Syntaxin developed bacterial-based protein therapeutics that inhibit cell secretion for the treatment of neurological, inflammatory and endocrine diseases. Lundbeckfonden BioCapital Investeringsår 2010 Acquired by Ipsen in 2013 Lokation Abingdon, United Kingdom